Mouse models of myeloproliferative neoplasms: JAK of all grades

In 2005, several groups identified a single gain-of-function point mutation in the JAK2 kinase that was present in the majority of patients with myeloproliferative neoplasms (MPNs). Since this discovery, much effort has been dedicated to understanding the molecular consequences of the JAK2V617F muta...

Full description

Bibliographic Details
Main Authors: Juan Li, David G. Kent, Edwin Chen, Anthony R. Green
Format: Article
Language:English
Published: The Company of Biologists 2011-05-01
Series:Disease Models & Mechanisms
Online Access:http://dmm.biologists.org/content/4/3/311
_version_ 1818313333858631680
author Juan Li
David G. Kent
Edwin Chen
Anthony R. Green
author_facet Juan Li
David G. Kent
Edwin Chen
Anthony R. Green
author_sort Juan Li
collection DOAJ
description In 2005, several groups identified a single gain-of-function point mutation in the JAK2 kinase that was present in the majority of patients with myeloproliferative neoplasms (MPNs). Since this discovery, much effort has been dedicated to understanding the molecular consequences of the JAK2V617F mutation in the haematopoietic system. Three waves of mouse models have been produced recently (bone marrow transplantation, transgenic and targeted knock-in), which have facilitated the understanding of the molecular pathogenesis of JAK2V617F-positive MPNs, providing potential platforms for designing and validating novel therapies in humans. This Commentary briefly summarises the first two types of mouse models and then focuses on the more recently generated knock-in models.
first_indexed 2024-12-13T08:32:05Z
format Article
id doaj.art-1473835664054d78b6cbee62dedd101a
institution Directory Open Access Journal
issn 1754-8403
1754-8411
language English
last_indexed 2024-12-13T08:32:05Z
publishDate 2011-05-01
publisher The Company of Biologists
record_format Article
series Disease Models & Mechanisms
spelling doaj.art-1473835664054d78b6cbee62dedd101a2022-12-21T23:53:44ZengThe Company of BiologistsDisease Models & Mechanisms1754-84031754-84112011-05-014331131710.1242/dmm.006817006817Mouse models of myeloproliferative neoplasms: JAK of all gradesJuan LiDavid G. KentEdwin ChenAnthony R. GreenIn 2005, several groups identified a single gain-of-function point mutation in the JAK2 kinase that was present in the majority of patients with myeloproliferative neoplasms (MPNs). Since this discovery, much effort has been dedicated to understanding the molecular consequences of the JAK2V617F mutation in the haematopoietic system. Three waves of mouse models have been produced recently (bone marrow transplantation, transgenic and targeted knock-in), which have facilitated the understanding of the molecular pathogenesis of JAK2V617F-positive MPNs, providing potential platforms for designing and validating novel therapies in humans. This Commentary briefly summarises the first two types of mouse models and then focuses on the more recently generated knock-in models.http://dmm.biologists.org/content/4/3/311
spellingShingle Juan Li
David G. Kent
Edwin Chen
Anthony R. Green
Mouse models of myeloproliferative neoplasms: JAK of all grades
Disease Models & Mechanisms
title Mouse models of myeloproliferative neoplasms: JAK of all grades
title_full Mouse models of myeloproliferative neoplasms: JAK of all grades
title_fullStr Mouse models of myeloproliferative neoplasms: JAK of all grades
title_full_unstemmed Mouse models of myeloproliferative neoplasms: JAK of all grades
title_short Mouse models of myeloproliferative neoplasms: JAK of all grades
title_sort mouse models of myeloproliferative neoplasms jak of all grades
url http://dmm.biologists.org/content/4/3/311
work_keys_str_mv AT juanli mousemodelsofmyeloproliferativeneoplasmsjakofallgrades
AT davidgkent mousemodelsofmyeloproliferativeneoplasmsjakofallgrades
AT edwinchen mousemodelsofmyeloproliferativeneoplasmsjakofallgrades
AT anthonyrgreen mousemodelsofmyeloproliferativeneoplasmsjakofallgrades